Give detailed comments on the health of the cash flow from operating activities for 2017 by referring to the amount published in their extract (below) and their published cash flow statement, focusing only on the following aspects in your discussion: - working capital management - ability to pay interest and dividends Note: the calculation of working capital cycle is not required.
AUDITED GROUP CASH FLOW STATEMENT 2017 in review 2017 R'000 2016 R000 ue EBITDA Cash intlowNouttiow) trom operations nterest income recetved Finance costs paid ncome taxos pald 787 383 40 734 (299 172) (160 232) 368 713 (280 537) 32 968 (165 4// 27 R64 billion R1.1 billion Net cash inflow/(outflow) from operating activities Cash flows from investing activities Purchase of property, plant and equipment Proceeds on the sale of property. plant and equipment (506 213) (117 885) 3 623 (119 062) 767 (5 454 161) (246 343) (119 513) 46 932 urchase of other intangibles assets Proceeds on the sale ot intangible assets 55 707 (83 0D3) 553 EBITDA Normalised HEPS ayment for acquisition of subsidiaries-net of cash Ropayments on doferred vendor llabllties Payments for the settlement of fareign exchange contracts Ropayment of loans advanced to related partios Loans advanced to related parties Loans advanced to external parties Repayment of loans advanced to external parties (10 825 11 608 (27 552) 30 1564 cents per share (16 854) 14 072 (6017 623) 30 30 Net cash utilised in investing activities (578 773) Cash flows from financing activities Proceed from issue of shares Proceed on the sale of troasury shares Payments made to acquire treasury shares Proceeds from borrowings ralsco Repayment of borrowings Repayment of loans from related pardes Finance lease payments Dividends paid 2 981 281 37 888 (137 678) 5 140 675 (1 663 244) (26 290) 1 803) 112 758 6218 071 557 232 6049 20 925 813 (475 062) Cash from operations Global healthcare business with 60% profit generated 21 57 066) 957 476 outside SA Net cash inflow from financing activities Nat increase/(decreasa) in cash and cash equivalents Cash and cash cquivalents at beginning of period Effect of exchange difference on cash balances 569 161 (22 396) (19 590) 527 175 127 510) 101 215 3 899 Three international acquisitions completed Cash and cash equivalents at end of period (22 396) AUDITED GROUP CASH FLOW STATEMENT 2017 in review 2017 R'000 2016 R000 ue EBITDA Cash intlowNouttiow) trom operations nterest income recetved Finance costs paid ncome taxos pald 787 383 40 734 (299 172) (160 232) 368 713 (280 537) 32 968 (165 4// 27 R64 billion R1.1 billion Net cash inflow/(outflow) from operating activities Cash flows from investing activities Purchase of property, plant and equipment Proceeds on the sale of property. plant and equipment (506 213) (117 885) 3 623 (119 062) 767 (5 454 161) (246 343) (119 513) 46 932 urchase of other intangibles assets Proceeds on the sale ot intangible assets 55 707 (83 0D3) 553 EBITDA Normalised HEPS ayment for acquisition of subsidiaries-net of cash Ropayments on doferred vendor llabllties Payments for the settlement of fareign exchange contracts Ropayment of loans advanced to related partios Loans advanced to related parties Loans advanced to external parties Repayment of loans advanced to external parties (10 825 11 608 (27 552) 30 1564 cents per share (16 854) 14 072 (6017 623) 30 30 Net cash utilised in investing activities (578 773) Cash flows from financing activities Proceed from issue of shares Proceed on the sale of troasury shares Payments made to acquire treasury shares Proceeds from borrowings ralsco Repayment of borrowings Repayment of loans from related pardes Finance lease payments Dividends paid 2 981 281 37 888 (137 678) 5 140 675 (1 663 244) (26 290) 1 803) 112 758 6218 071 557 232 6049 20 925 813 (475 062) Cash from operations Global healthcare business with 60% profit generated 21 57 066) 957 476 outside SA Net cash inflow from financing activities Nat increase/(decreasa) in cash and cash equivalents Cash and cash cquivalents at beginning of period Effect of exchange difference on cash balances 569 161 (22 396) (19 590) 527 175 127 510) 101 215 3 899 Three international acquisitions completed Cash and cash equivalents at end of period (22 396)
